Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 168
- By:
- Publication type:
- Article
Works matching IS 09566511 AND DT 2012 AND VI 24 AND IP 4
Results: 33
1
2
A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 167
- By:
- Publication type:
- Article
3
Efficacy of "radioguided occult lesion localization" (ROLL) versus "wire-guided localization" (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 166
- By:
- Publication type:
- Article
4
Combination anastrozole and fulvestrant in metastatic breast cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 165
- By:
- Publication type:
- Article
5
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 165
- By:
- Publication type:
- Article
6
Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 164
- By:
- Publication type:
- Article
7
Management of small HER2 overexpressing tumours.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 163
- By:
- Publication type:
- Article
8
Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9433 patients.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 163
- By:
- Publication type:
- Article
9
Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 162
- By:
- Publication type:
- Article
10
Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 161
- By:
- Publication type:
- Article
11
Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 160
- By:
- Publication type:
- Article
12
Semi-quantitative lymph node assessment of 18F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 160
- By:
- Publication type:
- Article
13
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 159
- By:
- Publication type:
- Article
14
Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 158
- By:
- Publication type:
- Article
15
Use of MRI in preoperative planning for women with newly diagnosed DCIS: risk or benefit?
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 157
- By:
- Publication type:
- Article
16
The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 156
- By:
- Publication type:
- Article
17
The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice?
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 155
- Publication type:
- Article
18
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 155
- By:
- Publication type:
- Article
19
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL -- CALGB 150007/150012, ACRIN 6657.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 154
- By:
- Publication type:
- Article
20
Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 153
- By:
- Publication type:
- Article
21
Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 152
- By:
- Publication type:
- Article
22
Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 152
- By:
- Publication type:
- Article
23
Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 151
- By:
- Publication type:
- Article
24
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 150
- By:
- Publication type:
- Article
25
T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2<sup>+</sup> prostate and breast cancer cells.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 149
- By:
- Publication type:
- Article
26
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4<sup>+</sup> T cells.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 148
- By:
- Publication type:
- Article
27
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 146
- By:
- Publication type:
- Article
28
Host epithelial geometry regulates breast cancer cell invasiveness.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 145
- By:
- Publication type:
- Article
29
Comprehensive molecular portraits of human breast tumours.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 144
- By:
- Publication type:
- Article
30
Estrogen receptor prevents p53-dependent apoptosis in breast cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 143
- By:
- Publication type:
- Article
31
Triple-Negative Breast Cancer.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 131
- By:
- Publication type:
- Article
32
Mammalian Target of Rapamycin Inhibitors in Breast Cancer Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 117
- By:
- Publication type:
- Article
33
Foreword.
- Published in:
- Current Medical Literature: Breast Cancer, 2012, v. 24, n. 4, p. 117
- By:
- Publication type:
- Article